MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$0.86
-0.06 (-6.41%)
Open$0.93
Previous Close$0.92
Day High$0.93
Day Low$0.85
52W High$3.06
52W Low$0.88
Volume—
Avg Volume1.82M
Market Cap118.20M
P/E Ratio—
EPS$-0.69
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+5,170.3% upside
Current
$0.86
$0.86
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.39M | 3.53M | 19.07M |
| Net Income | -97,529,881 | -129,809,069 | 5.86M |
| Profit Margin | -4,078.8% | -3,874.8% | 30.7% |
| EBITDA | -95,934,008 | -134,778,627 | 12.52M |
| Free Cash Flow | — | — | 4.46M |
| Rev Growth | -32.4% | -32.4% | +19.4% |
| Debt/Equity | 1.37 | 1.37 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |